Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Priority Review
Sort By
Newest First
1 / 1
1 / 1
Priority Review
Novartis Lung Cancer Drug Granted Priority FDA Review
Novartis
PR-M02-20-NI-010
Feb 11, 2020
M&A
AstraZeneca Agrees to Buy US FDA Priority Review Voucher from Sobi
Nice Insight
PR-M08-19-NI-083-2192
Aug 28, 2019
Priority Review
Melinta’s Antibiotic Baxdela Gets Priority Review from FDA for CAPB
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M07-19-NI-005
Jul 01, 2019
NDA
U.S. FDA Grants Priority Review For Vascepa® (Icosapent Ethyl) Supplemental New Drug Application Seeking Cardiovascular Risk Reduction Indication
Amarin
PR-M05-19-NI-080
May 29, 2019
FDA Acceptance
Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab (RTH258) for Patients with Wet AMD
Novartis
PR-M04-19-NI-053
Apr 17, 2019
Priority Review
FDA Grants Priority Review to Dupixent for Treatment of Adults with Severe Chronic Rhinosinusitis
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-017
Mar 12, 2019
FDA
FDA Gives Novartis Gene Replacement Therapy Application Priority Review
Emilie Branch
Pharma's Almanac
PAO-M12-18-NI-003
Dec 05, 2018
Drug Application
FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
Bayer
PR-M05-18-NI-115
May 31, 2018
CFDA
China FDA Publishes Guidance for Priority Review
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-18-NI-013
Jan 09, 2018